|
|
||||||||




* Division of Gastroenterology and Hepatology, University Hospital of Essen, Essen, Germany;
Division of Infectious Diseases & Immunology, University of Massachusetts Medical School, Worcester, MA 01605;
Division of Gastroenterology and Metabolism, South Essen Hospitals, Essen, Germany; and
Gastrointestinal Unit, Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114
Intestinal epithelial cells (IEC) are constantly exposed to both high concentrations of the bacterial ligand LPS and the serine protease trypsin. MD-2, which contains multiple trypsin cleavage sites, is an essential accessory glycoprotein required for LPS recognition and signaling through TLR4. The aim of this study was to characterize the expression and subcellular distribution of intestinal epithelial MD-2 and to delineate potential functional interactions with trypsin and then alteration in inflammatory bowel disease (IBD). Although MD-2 protein expression was minimal in primary IEC of normal colonic or ileal mucosa, expression was significantly increased in IEC from patients with active IBD colitis, but not in ileal areas from patients with severe Crohns disease. Endogenous MD-2 was predominantly retained in the calnexin-calreticulin cycle of the endoplasmic reticulum; only a small fraction was exported to the Golgi. MD-2 expression correlated inversely with trypsin activity. Biochemical evidence and in vitro experiments demonstrated that trypsin exposure resulted in extensive proteolysis of endogenous and soluble MD-2 protein, but not of TLR4 in IEC, and was associated with desensitization of IEC to LPS. In conclusion, the present study suggests that endoplasmic reticulum-associated MD-2 expression in IBD may be altered by ileal protease in inflammation, leading to impaired LPS recognition and hyporesponsiveness through MD-2 proteolysis in IEC, thus implying a physiologic mechanism that helps maintain LPS tolerance in the intestine.
This article has been cited by other articles:
![]() |
K. Takahashi, Y. Sugi, A. Hosono, and S. Kaminogawa Epigenetic Regulation of TLR4 Gene Expression in Intestinal Epithelial Cells for the Maintenance of Intestinal Homeostasis J. Immunol., November 15, 2009; 183(10): 6522 - 6529. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ey, A. Eyking, G. Gerken, D. K. Podolsky, and E. Cario TLR2 Mediates Gap Junctional Intercellular Communication through Connexin-43 in Intestinal Epithelial Barrier Injury J. Biol. Chem., August 14, 2009; 284(33): 22332 - 22343. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, Y. Ouyang, Y. Guner, H. R. Ford, and A. V. Grishin Ubiquitin-Editing Enzyme A20 Promotes Tolerance to Lipopolysaccharide in Enterocytes J. Immunol., July 15, 2009; 183(2): 1384 - 1392. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Rallabhandi, Q. M. Nhu, V. Y. Toshchakov, W. Piao, A. E. Medvedev, M. D. Hollenberg, A. Fasano, and S. N. Vogel Analysis of Proteinase-activated Receptor 2 and TLR4 Signal Transduction: A NOVEL PARADIGM FOR RECEPTOR COOPERATIVITY J. Biol. Chem., September 5, 2008; 283(36): 24314 - 24325. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |